Mink Therapeutics Inc
NASDAQ:INKT

Watchlist Manager
Mink Therapeutics Inc Logo
Mink Therapeutics Inc
NASDAQ:INKT
Watchlist
Price: 11.66 USD 0.6% Market Closed
Market Cap: 54.7m USD

Wall Street
Price Targets

INKT Price Targets Summary
Mink Therapeutics Inc

Wall Street analysts forecast INKT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INKT is 39.78 USD with a low forecast of 35.35 USD and a high forecast of 45.15 USD.

Lowest
Price Target
35.35 USD
203% Upside
Average
Price Target
39.78 USD
241% Upside
Highest
Price Target
45.15 USD
287% Upside
Mink Therapeutics Inc Competitors:
Price Targets
4593
Healios KK
125% Upside
ORKA
Oruka Therapeutics Inc
57% Upside
MIRM
Mirum Pharmaceuticals Inc
29% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
91% Upside
FHTX
Foghorn Therapeutics Inc.
97% Upside
PLUR
Pluri Inc
271% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
30% Upside
RYTM
Rhythm Pharmaceuticals Inc
22% Upside

Revenue
Forecast

Revenue Estimate
Mink Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Mink Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Mink Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-30%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INKT's stock price target?
Price Target
39.78 USD

According to Wall Street analysts, the average 1-year price target for INKT is 39.78 USD with a low forecast of 35.35 USD and a high forecast of 45.15 USD.

Back to Top